Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5446 to 5460 of 7685 results

  1. Histological margins: What is the optimal histological excision margin in stage 0 melanoma?

    Recommendation ID NG14/04 Question Histological margins: What is the optimal histological excision margin in stage 0 melanoma? Any

    Research recommendation
    Published
    4 August 2022

  2. Cardiac MRI versus other imaging techniques for diagnosing heart failure:- What is the optimal imaging technique for the diagnosis of heart failure?

    Recommendation ID NG106/2 Question Cardiac MRI versus other imaging techniques for diagnosing heart failure:- What is the optimal imaging

    Research recommendation
    Published
    17 December 2018

  3. Management of anaemia of CKD with concurrent illness: What is the optimal management (in terms of clinical and cost effectiveness) of anaemia of CKD in people who are receiving erythropoietic stimulating agents (ESAs) and have a significant concurrent acute infectious illness?

    Recommendation ID NG203/22 Question Management of anaemia of CKD with concurrent illness: What is the optimal management (in terms of clinical

    Research recommendation
    Published
    30 September 2021

  4. The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing heart failure:- What is the optimal NT-proBNP threshold for the diagnosis of heart failure in people with atrial fibrillation?

    Recommendation ID NG106/3 Question The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing heart failure:- What

    Research recommendation
    Published
    17 December 2018

  5. Length of bed rest after spinal cord injury: What is the effectiveness and cost effectiveness of short-term bed rest compared with long-term bed rest on functional outcomes in people with complex rehabilitation needs after traumatic injury that involves the spinal column or spinal cord injury?

    Recommendation ID NG211/05 Question Length of bed rest after spinal cord injury: What is the effectiveness and cost effectiveness of short-term

    Research recommendation
    Published
    1 February 2022

  6. What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs) compared with a standard prophylactic dose for venous thromboembolism (VTE) prophylaxis in young people under 18 years with COVID-19?

    Recommendation ID NG191/3 Question What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs)

    Research recommendation
    Published
    10 August 2021

  7. What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19?

    Recommendation ID NG191/2 Question What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis

    Research recommendation
    Published
    10 August 2021

  8. What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2 variants?

    Recommendation ID NG191/15 Question What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2

    Research recommendation
    Published
    9 March 2022

  9. What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological venous thromboembolism (VTE) prophylaxis for people with COVID-19, with or without additional risk factors for VTE?

    Recommendation ID NG191/1 Question What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological

    Research recommendation
    Published
    10 August 2021

  10. Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability of advocacy as a means of supporting people to make decisions?

    Recommendation ID NG108/3 Question Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability

    Research recommendation
    Published
    18 December 2018

  11. Dementia education and training programmes for family members and carers:- What is the effectiveness, cost effectiveness and acceptability of training programmes (forexample, in the use of life story work) for families of people growing older with learning disabilities who have dementia or are at risk of developing it?

    Recommendation ID NG96/4 Question Dementia education and training programmes for family members and carers:- What is the effectiveness

    Research recommendation
    Published
    29 November 2018

  12. What is the effectiveness, cost effectiveness and safety of the combination of casirivimab and imdevimab for treating COVID-19 in people with particular clinical characteristics (for example, people who are seropositive, of unknown serostatus, immunocompromised, or with specific comorbidities and within both the seropositive and seronegative groups, according to vaccination status or history of natural infection)?

    Recommendation ID NG191/8 Question What is the effectiveness, cost effectiveness and safety of the combination of casirivimab and imdevimab

    Research recommendation
    Published
    21 October 2021

  13. What is the effectiveness, cost effectiveness and safety of using a combination of casirivimab and imdevimab at doses other than 8 g for treating COVID-19?

    Recommendation ID NG191/7 Question What is the effectiveness, cost effectiveness and safety of using a combination of casirivimab and imdevimab

    Research recommendation
    Published
    12 November 2021

  14. Targeted support: What is the effectiveness (including long-term effectiveness) and cost effectiveness of targeted group or individual interventions for children and young people who have been identified as needing additional mental health support, and does it vary by ethnicity, socioeconomic status or other cultural and personal factors?

    Recommendation ID NG223/03 Question Targeted support: What is the effectiveness (including long-term effectiveness) and cost effectiveness

    Research recommendation
    Published
    4 August 2022

  15. What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD?

    Recommendation ID CG181/1 Question What is the effectiveness of age alone and other routinely available risk factors compared with the

    Research recommendation
    Published
    9 June 2015